Clinical trial
A Phase III Study With Freeze Dried HL10, Three Dosages of 200 mg/kg Ideal Body Weight Versus Standard Therapy in ALI/ARDS Patients
NCT00742482 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Study With Freeze Dried HL10, Three Dosages of 200 mg/kg Ideal Body Weight Versus Standard Therapy in ALI/ARDS Patients
- Lead sponsor
- LEO Pharma
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2003
- Completion date
- June 30, 2005
- Enrollment
- 418 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
acute lung injury, acute respiratory distress syndrome